| Title |
Author |
Type |
Date |
Words |
| Mathematical Modelling of the Inhibitory Role of Regulatory T Cells in Tumor Immune Response. |
Yang, Zhongtao; Yang, Cuihong; Dong, Yueping; Takeuchi, Yasuhiro |
|
Aug 31, 2020 |
11877 |
| Gritstone Oncology reports Q2 EPS (69c), consensus (73c). |
|
Financial report |
Aug 5, 2020 |
211 |
| Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets. |
Chen, Chao; Liu, Songming; Qu, Ruokai; Li, Bo |
|
Jul 31, 2020 |
4524 |
| Genocea to present preliminary data on GEN-009 with checkpoint inhibitors. |
|
|
Jul 30, 2020 |
217 |
| Avalon GloboCare expects to begin first-in-human trial with AVA-011 in 1Q21. |
|
|
Jul 13, 2020 |
239 |
| INeo-Epp: A Novel T-Cell HLA Class-I Immunogenicity or Neoantigenic Epitope Prediction Method Based on Sequence-Related Amino Acid Features. |
Wang, Guangzhi; Wan, Huihui; Jian, Xingxing; Li, Yuyu; Ouyang, Jian; Tan, Xiaoxiu; Zhao, Yong; Lin, |
|
Jun 30, 2020 |
6184 |
| Genocea presents updated long-term data from GEN-009 Phase 1/2a trial. |
|
|
May 29, 2020 |
335 |
| TRANSGENE AND NEC DEMONSTRATE NEOANTIGEN PREDICTION. |
|
|
May 27, 2020 |
798 |
| Neon Therapeutics announces acceptance of CTA application for NEO-PTC-01. |
|
|
Apr 30, 2020 |
163 |
| Global Neoantigen Cancer Vaccine Market is Projected to Reach $1826.1 Million by End of the Forecast Period, 2030. |
|
|
Jan 14, 2020 |
1077 |
| Could Increased Expression of Hsp27, an "Anti-Inflammatory" Chaperone, Contribute to the Monocyte-Derived Dendritic Cell Bias towards Tolerance Induction in Breast Cancer Patients? |
de Azevedo-Santos, Ana Paula Silva; Rocha, Mirtes Castelo Branco; Guimaraes, Sulayne Janayna Araujo; |
|
Dec 31, 2019 |
4915 |
| Combination with Stereotactic Body Radiotherapy Offers a Promising Strategy to Overcome Resistance to Immunotherapy in Advanced Renal Cell Cancer. |
Sun, Xiaowen; Gan, Lu; Na, Aru; Ge, Lingling; Chen, Baoqing; Liu, Jiaming |
|
Dec 31, 2019 |
9231 |
| A Comprehensive Survey of Genomic Alterations in Gastric Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets. |
Chen, Chao; Zhou, Qiming; Wu, Riping; Li, Bo; Chen, Qiang; Zhang, Xiuqing; Shi, Chunmei |
|
Nov 30, 2019 |
5336 |
| NEC and Vaximm Forge Clinical Trial Collaboration. |
|
|
Nov 14, 2019 |
224 |
| Genocea presents preclinical research on inhibitory neoantigens. |
|
|
Nov 5, 2019 |
395 |
| Genocea Biosciences reveals 'outstanding' data on its neoantigen immunotherapy aimed to treat cancer. |
|
|
Oct 31, 2019 |
133 |
| Genocea to present interim results from Phase 1/2a trial for GEN-009. |
|
|
Sep 27, 2019 |
152 |
| Applied DNA Sciences, Takis/Evvivax vaccine candidates showed tumor reduction. |
|
|
Sep 19, 2019 |
324 |
| Valo Therapeutics licenses the PeptiENV Technology from the University of Helsinki for the treatment of multiple cancers. |
|
|
Sep 3, 2019 |
265 |
| Valo Therapeutics licenses the PeptiENV Technology from the University of Helsinki for the treatment of multiple cancers. |
|
|
Sep 3, 2019 |
261 |
| Neoantigen Targeted Therapies Market, 2030. |
|
|
Aug 6, 2019 |
985 |
| Neon Therapeutics reports Q2 EPS (79c), consensus (78c). |
|
Financial report |
Aug 6, 2019 |
146 |
| NEC Acquires Norwegian Bioinformatics Company, OncoImmunity AS. |
|
|
Jul 29, 2019 |
431 |
| Mobile app 'finds anti-cancer molecules in food'. |
|
|
Jul 21, 2019 |
140 |
| New Immune Data from Ongoing ADXS-NEO Phase 1 Study Support Clinical Potential for Neoantigen-Directed Immunotherapies. |
|
|
Jul 16, 2019 |
903 |
| Gilead subsidiary Kite announces plans for viral vectors facility in California. |
|
|
Jul 16, 2019 |
111 |
| Neon Therapeutics' Neoantigen vaccine shows prolonged Progression-Free Survival. |
|
|
Jul 15, 2019 |
236 |
| Advaxis annnounces new immune data from ongoing ADXS-NEO Phase 1 clinical trial. |
|
|
Jul 15, 2019 |
255 |
| Advaxis to Increase Focus on Neoantigen-Directed Immunotherapies, Closes Phase 3 AIM2CERV Study. |
|
|
Jun 28, 2019 |
400 |
| Moderna Presents Interim Data from Phase 1 Study of mRNA Personalised Cancer Vaccine at 2019 ASCO Annual Meeting. |
|
|
Jun 5, 2019 |
647 |
| Genocea presents GEN-009 data at ASCO. |
|
|
Jun 3, 2019 |
120 |
| NEC (TYO: 6701)--NEC initiates AI-driven drug discovery business targeting a business valuation of [yen] 300 billion by 2025--27/5/2019. |
|
|
May 27, 2019 |
507 |
| NEC Becomes the First Japanese Company to Join the TESLA Consortium's Fight Against Cancer. |
|
|
May 14, 2019 |
371 |
| Gritstone Oncology reports Q1 EPS (62c), consensus (65c). |
|
Financial report |
May 13, 2019 |
219 |
| Gritstone Oncology reports Q4 EPS (61c), consensus (65c). |
|
Financial report |
Mar 28, 2019 |
178 |
| Flow Pharma, OncoImmunity AS partner for the Development of FlowVax Personalised Cancer Vaccines. |
|
|
Mar 13, 2019 |
404 |
| Transgene to Start Clinical Development of Lead Myvac Individualised Immunotherapy, TG4050, in 2019, Under Partnership with NEC. |
|
|
Mar 7, 2019 |
491 |
| NOVEL DIAGNOSTIC AND THERAPEUTIC APPROACHES TO THE TREATMENT OF OVARIAN CANCER/SAVREMENI DIJAGNOSTICKO-TERAPIJSKI PRISTUP U LECENJU KARCINOMA JAJNIKA. |
Durdevic, Srdan; Stojanovic, Sanja; Basta Nikolic, Marijana; Nikolic, Dragan |
Clinical report |
Jan 1, 2019 |
2920 |
| Ykl-40 and cancer antigen 72-4 as new and promising diagnostic and prognostic markers for endometrial cancer/Endometriyal kanser icin yeni ve umut verici tani ve prognostik belirtecler olarak YKL-40 ve kanser antijen 72-4. |
Karatas, Suat; Sal, Veysel; Kahramanoglu, Ilker; Demirkiran, Fuat; Bese, Tugan; Arvas, Macit; Sofiye |
Report |
Dec 1, 2018 |
5223 |
| Neon Therapeutics presents Phase 1b data on NEO-PV01 vaccine. |
|
|
Oct 22, 2018 |
188 |
| Kite, HiFiBiO announce research collaboration. |
|
|
Oct 2, 2018 |
186 |
| Stellar Biotechnologies to supply KLH to National Institutes of Health. |
|
|
Sep 5, 2018 |
143 |
| Bristol-Myers Squibb, Gritstone Oncology Forge Clinical Research Collaboration to Evaluate Novel Immunotherapy Approach in Advanced Solid Tumors. |
|
|
Aug 2, 2018 |
610 |
| Bristol-Myers Squibb, Gritstone Oncology Partner to Evaluate Neoantigen Immunotherapy in Advanced Solid Tumors. |
|
|
Jul 24, 2018 |
383 |
| Targovax ASA awarded European Patent for mutant-RAS specific neoantigen vaccine TG02. |
|
|
Jun 19, 2018 |
244 |
| Targovax ASA awarded European Patent for mutant-RAS specific neoantigen vaccine TG02. |
|
|
Jun 19, 2018 |
240 |
| First Patient Dosed in Investigational Personalized Neoantigen Immunotherapy Trial with ADXS-NEO. |
|
|
Jun 13, 2018 |
288 |
| Personalized Therapy Promising in Metastatic Breast Cancer; Adaptive transfer of mutant-protein-specific tumor-infiltrating lymphocytes leads to disease regression. |
|
|
Jun 4, 2018 |
186 |
| Adrian Woolfson, M.D., Ph.D Named as Chief Medical Officer for Nouscom. |
|
|
May 31, 2018 |
170 |
| Nouscom names new chief medical officer. |
|
|
May 30, 2018 |
226 |
| Nouscom names new chief medical officer. |
|
|
May 30, 2018 |
222 |
| Nouscom names Adrian Woolfson as CMO. |
|
|
May 29, 2018 |
162 |
| Nouscom names Adrian Woolfson as CMO. |
|
|
May 29, 2018 |
158 |
| Advaxis says data shows potential of ADXS-NEO as anti-cancer immunotherapy agent. |
|
|
May 11, 2018 |
202 |
| Neon Therapeutics Treats First Patient in Clinical Trial of NEO-PV-01 Cancer Vaccine in Combination with Keytruda and Chemotherapy. |
|
|
May 10, 2018 |
298 |
| Aduro Biotech says pLADD therapy induces both innate, adaptive immunity. |
|
|
Apr 26, 2018 |
218 |
| Next Gen Immuno-Oncology Congress-USA will discuss advancements in cancer immunotherapy, clinical de. |
|
|
Mar 5, 2018 |
546 |
| Neoantigen profiling predicts response to immunotherapy. |
Osterweil, Neil |
|
Feb 1, 2018 |
1077 |
| Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica. |
Hernandez-Luna, Marco Antonio; Luria-Perez, Rosendo |
|
Jan 1, 2018 |
10809 |
| Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens. |
Pan, Ren-You; Chung, Wen-Hung; Chu, Mu-Tzu; Chen, Shu-Jen; Chen, Hua-Chien; Zheng, Lei; Hung, Shuen- |
|
Jan 1, 2018 |
6452 |
| Cancer Immunotherapy and Identification of Prognostic and Predictive Biomarkers. |
Criscitiello, Carmen; Santangelo, Michele; Loupakis, Fotios |
|
Jan 1, 2018 |
710 |
| The Evolution of Radiation Therapy in Metastatic Breast Cancer: From Local Therapy to Systemic Agent. |
Jutzy, Jessica M.S.; Lemons, Jeffrey M.; Luke, Jason J.; Chmura, Steven J. |
Report |
Jan 1, 2018 |
6191 |
| Diffuse Bone Marrow Metastasis as the Initial Presentation of an Occult Breast Cancer. |
Fan, Frank S.; Yang, Chung-Fan; Wang, Yi-Fen |
|
Jan 1, 2018 |
3043 |
| Collaborative Clinical Study Will Examine Neon Therapeutics' Cancer Vaccine in Combination with Merck's Keytruda and Chemotherapy. |
|
Clinical report |
Dec 8, 2017 |
248 |
| Neon Therapeutics Raises USD 106m in Crossover Series B Financing. |
|
|
Dec 7, 2017 |
269 |
| NousCom reveals preclinical data showing neoantigen-based vaccine synergises with NKTR-214. |
|
|
Nov 13, 2017 |
219 |
| NousCom reveals preclinical data showing neoantigen-based vaccine synergises with NKTR-214. |
|
|
Nov 13, 2017 |
215 |
| DECREASE IN LEVEL OF CA-125 AFTER SURGICAL TREATMENT OF ENDOMETRIOSIS. |
|
Report |
Sep 30, 2017 |
1944 |
| Neon Therapeutics, Apexigen to Collaborate in Clinical Trial for Metastatic Melanoma Treatment. |
|
|
Jul 26, 2017 |
289 |
| Vedantra Pharmaceuticals, Neon Therapeutics Forge Joint Research Collaboration to Develop Cancer Vaccines. |
|
|
Mar 14, 2017 |
388 |
| The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses. |
Dolgun, Zehra Nihal; Kabaca, Canan; Karateke, Ates; Iyibozkurt, Cem; Inan, Cihan; Altintas, Ahmet Sa |
Report |
Mar 1, 2017 |
4817 |
| Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast Cancer. |
Page, Karen; Guttery, David S.; Fernandez-Garcia, Daniel; Hills, Allison; Hastings, Robert K.; Luo, |
Report |
Feb 1, 2017 |
5875 |
| Aduro Biotech signs exclusive license agreement with Stanford University. |
|
|
Jan 20, 2017 |
216 |
| Aduro Biotech signs exclusive license agreement with Stanford University. |
|
|
Jan 20, 2017 |
212 |
| Pure MHC signs oncology research partnership with AbbVie. |
|
|
Jan 10, 2017 |
193 |
| Pure MHC signs oncology research partnership with AbbVie. |
|
|
Jan 10, 2017 |
189 |
| Selection of DNA Aptamers for Ovarian Cancer Biomarker CA125 Using One-Pot SELEX and High-Throughput Sequencing. |
Scoville, Delia J.; Uhm, Tae Kyu Brian; Shallcross, Jamie A.; Whelan, Rebecca J. |
Report |
Jan 1, 2017 |
6964 |
| Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies. |
Ye, Baixin; Stary, Creed M.; Gao, Qingping; Wang, Qiongyu; Zeng, Zhi; Jian, Zhihong; Gu, Lijuan; Xio |
|
Jan 1, 2017 |
9611 |
| A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion. |
Hogendorf, Piotr; Skulimowski, Aleksander; Durczynski, Adam; Kumor, Anna; Poznanska, Grahyna; Olesna |
Report |
Jan 1, 2017 |
5494 |
| A blood test for early detection of lung cancer. |
Peek, Laura J.; Jett, James R. |
|
Dec 1, 2016 |
1479 |
| Evaluation of HE4, CA-125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) in the preoperative assessment of patients with adnexal mass. |
Musalhi, Khawla Al; Kindi, Manal Al; Aisary, Faiza Al; Ramadhan, Fatma; Rawahi, Thuraya Al; Hatali, |
Report |
Sep 1, 2016 |
5543 |
| AbbVie, CytomX Therapeutics. |
|
|
Jun 1, 2016 |
360 |
| Agreement seeks to advance stem-to-T-cell program. |
|
|
Feb 29, 2016 |
393 |
| Research agreement seeks to advance Stem-to-T-Cell program. |
|
|
Feb 22, 2016 |
392 |
| Research agreement seeks to advance Stem-to-T-Cell program. |
|
|
Feb 22, 2016 |
393 |
| Postoperative CA19-9 change is a useful predictor of intrahepatic cholangiocarcinoma survival following liver resection. |
Yoo, Tae; Park, Sang-Jae; Han, Sung-Sik; Kim, Seong Hoon; Lee, Seung Duk; Kim, Young-Kyu; Kim, Tae H |
Report |
Jan 1, 2016 |
3844 |
| Autoantibody response to ZRF1 and KRR1 SEREX antigens in patients with breast tumors of different histological types and grades. |
Dyachenko, Lada; Havrysh, Kristina; Lytovchenko, Anita; Dosenko, Irina; Antoniuk, Stepan; Filonenko, |
Report |
Jan 1, 2016 |
4977 |
| Validity of cancer antigen-125 (CA-125) and risk of malignancy index (RMI) in the diagnosis of ovarian cancer. |
Musalhi, Khawla Al-; Kindi, Manal Al-; Ramadhan, Fatma; Rawahi, Thuraya Al-; Hatali, Khalsa Al-; Mul |
Report |
Nov 1, 2015 |
4503 |
| Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. |
Lucarelli, Giuseppe; Ditonno, Pasquale; Bettocchi, Carlo; Vavallo, Antonio; Rutigliano, Monica; Gall |
Clinical report |
Jan 1, 2014 |
4247 |
| A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy. |
Chung, Dong-Sup; Shin, Hye-Jin; Hong, Yong-Kil |
Report |
Jan 1, 2014 |
14797 |
| CD8+ TIL recruitment may revert the association of MAGE A3 with aggressive features in thyroid tumors. |
Martins, Mariana Bonjiorno; Marcello, Marjory Alana; Batista, Fernando de Assis; Cunha, Lucas Leite; |
Report |
Jan 1, 2014 |
4661 |
| The rise and fall of CA 19-9. |
Bernon, M.; Thomson, S.R.; Jonas, E. |
Editorial |
Nov 1, 2013 |
1001 |
| Astronomically high CA 19-9 in a patient with a benign lesion. |
Rao, Nitin A.R.; Satyaprakash, B.S. |
Letter to the editor |
Nov 1, 2013 |
560 |
| Nanotechnology Used to Produce Biological Carriers of Breast Cancer Tumor Antigens. |
|
|
Aug 22, 2013 |
308 |
| Unleashing the power of proteomics to develop blood-based cancer markers. |
Taguchi, Ayumu; Hanash, Samir M. |
Report |
Jan 1, 2013 |
5610 |
| Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine. |
Li, Xiaosong; Min, Min; Du, Nan; Gu, Ying; Hode, Tomas; Naylor, Mark; Chen, Dianjun; Nordquist, Robe |
|
Jan 1, 2013 |
6200 |
| Serum CA-125 versus ultrasound examination in differentiating between benign and malignant ovarian masses. |
Farnaz; Hassan, Lubna |
Report |
Sep 30, 2012 |
1373 |
| Immunohistochemical expression of Ki-67, PCNA and CD34 in astrocytomas: a clinicopathological Study. |
Chaloob, Mohammed Kassim; Ali, Hussam Hasson; Qasim, Ban Jumaa; Mohammed, Ahmed Salahaldeen |
Report |
Sep 1, 2012 |
4472 |
| The values of CA-125, progesterone, [beta]-HCG and estradiol in the early prediction of ectopic pregnancy. |
Abdul-Hussein, Meena M.; Abdul-Rasheed, Omar F.; Al-Moayed, Hala Abdul Qadir |
Clinical report |
Mar 1, 2012 |
3068 |
| Ovarian cancer: recent studies shed light on early detection of ovarian cancer--but it's not a green light for routine screening. Until promising avenues of research lead further, refer women who have an adnexal mass, an elevated CA-125 level, and troubling ultrasonographic findings to a specialist--early. |
Mutch, David G.; Kizer, Nora |
Brief article |
Jul 1, 2010 |
280 |
| Ultrasonography in combination with serum ca-125 can facilitate early referral to a subspecialist. |
|
|
Jul 1, 2010 |
627 |
| Merkel cell polyomavirus in cutaneous swabs. |
Foulongne, Vincent; Kluger, Nicolas; Dereure, Olivier; Mercier, Gregoire; Moles, Jean-Pierre; Guillo |
|
Apr 1, 2010 |
2033 |
| CA125 monitoring not beneficial in ovarian Ca. |
Dales, Mary Jo M. |
Report |
Jul 1, 2009 |
971 |
| Monitoring CA125 after ovarian cancer provides no benefit. |
Dales, Mary Jo M. |
|
Jun 15, 2009 |
700 |
| CA 125 + ultrasound find early ovarian cancer. |
Sullivan, Michele G. |
Report |
Apr 15, 2009 |
584 |
| Roche Holding AG, the world's biggest maker of tumor drugs, said its Herceptin treatment helped keep breast cancer from worsening in a study. |
|
Brief article |
Dec 15, 2008 |
320 |
| Roche Holding AG, the world's biggest maker of tumor drugs, said a late-stage study showed its Herceptin medicine helped slow the spread of breast cancer when combined with its chemotherapy treatment Xeloda. |
|
Brief article |
Jun 2, 2008 |
193 |
| Identification of pro-MMP-7 as a serum marker for renal cell carcinoma by use of proteomic analysis. |
Sarkissian, Gaiane; Fergelot, Patricia; Lamy, Pierre-Jean; Patard, Jean-Jacques; Culine, Stephane; J |
|
Mar 1, 2008 |
5208 |
| WU polyomavirus in children, Canada. |
Abed, Yacine; Wang, David; Boivin, Guy |
|
Dec 1, 2007 |
1828 |
| Arch Surg: Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. |
Cwik, G.; Wallner, G.; Skoczylas, T. |
Brief article |
Apr 1, 2007 |
240 |
| Cytokeratin and epithelial membrane antigen expression in angiosarcomas: an immunohistochemical study of 33 cases. |
Abbadi, Mousa A. Al-; Almasri, Nidal M.; Quran, Samer Al-; Wilkinson, Edward J. |
Clinical report |
Feb 1, 2007 |
2798 |
| Pattern of biomarkers detects early-stage ovarian cancer. |
Bates, Betsy |
|
Apr 15, 2006 |
565 |
| Analysis of T-cell receptor V[beta] gene repertoires after immune stimulation and in malignancy by use of padlock probes and microarrays. |
Baner, Johan; Marits, Per; Nilsson, Mats; Winqvist, Ola; Landegren, Ulf |
|
Apr 1, 2005 |
5063 |
| Treatment combinations stall colorectal cancer. (Cancer Advance). |
Seppa, N. |
|
Jun 7, 2003 |
491 |
| A comparative study of four serological tumor markers for the detection of breast cancer. |
Hall, Margot |
|
Apr 1, 2002 |
4165 |
| Active Biotech gets UK approval for new cancer study. |
|
Brief Article |
Feb 6, 2002 |
126 |
| Results of BRCA Gene Testing Often Affects Choice of Therapy. |
Finn, Robert |
|
Jul 1, 2001 |
250 |
| Rapid screening method for osteoclast differentiation in vitro that measures tartrate-resistant acid phosphatase 5b activity secreted into the culture medium. |
Alatalo, Sari L.; Halleen, Jussi M.; Hentunen, Teuvo A.; Monkkonen, Jukka; Vaananen, H. Kalervo |
|
Nov 1, 2000 |
2078 |
| The "watch and wait" approach to prostate cancer. |
|
|
Jul 1, 1994 |
131 |
| Waving a red flag against melanoma. |
Ezzell, Carol |
|
Dec 14, 1991 |
700 |
